NASDAQ:APRE | Profit Breakdown | Aprea Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2017-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$4.03M-$3.59M
2026-03-31-$3.43M-$3.29M
2025-12-31-$2.64M-$2.46M
2025-09-30-$3.12M-$2.97M
2025-06-30-$3.39M-$3.24M
2025-03-31-$4.09M-$3.93M
2024-12-31-$3.23M-$2.89M
2024-09-30-$4.1M-$3.78M
2024-06-30-$3.85M-$3.47M
2024-03-31-$3.15M-$2.81M
2023-12-31-$3.67M-$3.44M
2023-09-30-$3.52M-$3.2M
2023-06-30-$3.65M-$3.26M
2023-03-31-$4.62M-$4.38M
2022-12-31-$2.65M-$2.44M
2022-09-30-$4.2M-$4.02M
2022-06-30-$98.47M-$98.26M
2022-03-31-$7.94M
2021-12-31-$7.76M
2021-09-30-$9.45M
2021-06-30-$10.25M
2021-03-31-$9.67M
2020-12-31-$15.39M
2020-09-30-$12.32M
2020-06-30-$16.37M
2020-03-31-$9.4M
2019-12-31-$13.07M
2019-09-30-$6.25M
2019-06-30-$5.26M
2019-03-31-$3.48M
2018-12-31-$4.68M
2018-09-30-$3.14M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$13.23M-$12.6M
2024-12-31-$14.32M-$12.96M
2023-12-31-$15.47M-$14.29M
2022-12-31-$113.39M-$112.66M
2021-12-31-$37.45M-$37.13M
2020-12-31-$53.48M
2019-12-31-$28.06M
2018-12-31-$15.53M
2017-12-31-$15.19M